Lancet Diabetes & Endocrinology

Diabetes support at work: an unmet need
The Lancet Diabetes Endocrinology
Social learning theories and metabolic health: the centenary of Bandura's birth
Koch M, McQueen D, Terclavers L and Sattar N
Primary aldosteronism and plasma renin targets
Fay KS and Cohen DL
The road towards standardisation in cyclic Cushing's syndrome
Niculescu DA
The importance of science communication surrounding weight-loss drugs
Yeo GSH
From reproduction to metabolism: FSH as a key modulator in menopause
Chedraui P, Barbagallo F, Cannarella R, Calogero AE and Nappi RE
Post-treatment renin status and cardiovascular, renal, and mortality outcomes in medically treated primary aldosteronism: a systematic review and meta-analysis
Katsuragawa S, Le MV, Fuller PJ and Yang J
Renin suppression persists in many patients with primary aldosteronism despite targeted medical treatment, which might indicate suboptimal mineralocorticoid receptor blockade. This study systematically reviewed the evidence for an association between post-treatment renin status and cardiovascular, renal, and mortality outcomes in medically treated primary aldosteronism.
Safeguarding natural intelligence: the case for renewed action on iodine sufficiency in the UK
Taylor PN, Prentice M, Boelaert K and Lazarus J
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study
Nowak E, Zhang Q, Zhang S, Zhao Y, Ye H, Machado MC, Moises CCS, Tóth M, Stark J, Yuen KCJ, Gurnell M, MacFarlane J, McCormack A, Govinna M, Gilis-Januszewska A, Minasyan M, Bonaventura I, Czepielewski MA, Ferriere A, Gadelha M, Isidori AM, Kastelan D, Maiter D, Tabarin A, Alexandraki KI, Chang J, Frontera ED, Hanzu FA, Matikainen N, Miljic D, Pichler R, Popovic V, Spencer-Segal JL, Tordjman K, Akirov A, Araujo-Castro M, Arvat E, Bancos I, Bioletto F, Burman P, Castinetti F, Detomas M, Fassnacht M, Feelders RA, Fountas A, Igaz P, Ilic S, Isand K, Kaltsas G, Meyer G, Parasiliti-Caprino M, Newell-Price J, Ragnarsson O, Valassi E, Vila G, Wass J, Yoel U, Fleseriu M and Reincke M
Cyclic Cushing's syndrome (cCS) features fluctuating cortisol secretion, often causing diagnostic errors or delays, and possibly poorer outcomes. We aimed to identify unpublished cCS cases to characterise clinical challenges and guide strategies for improving outcomes by characterising cycle patterns, peak frequency, and evaluating complications.
The long and winding road to precision diabetology
Roden M
Does continuous glucose monitoring deliver in gestational diabetes?
Ringholm L
Heterogeneity in type 2 diabetes trajectories: informing public health approaches
Pearson-Stuttard J and Critchley JA
The rise of thyroid cancer incidence in adolescents and young adults
Porcelli T and Schlumberger M
Thyroid cancer in adolescents and young adults: a population-based study in 185 countries worldwide
Li M, Dal Maso L, Pizzato M, Rumgay H and Vaccarella S
Cancer burden among adolescents and young adults (AYAs) aged 15-39 years has increased during the past two decades, with thyroid cancer being a major contributor. We aimed to comprehensively evaluate trends and the current burden of thyroid cancer among AYAs globally.
Trajectories of type 2 diabetes and cancer in 330 000 individuals with prediabetes: 20-year observational study in England
Zaccardi F, Ling S, Gillies C, Brown K, Davies MJ and Khunti K
Higher than normal glucose concentrations have been linked to an increased risk of cancer. We aimed to describe the disease trajectories from prediabetes to cancer, accounting for the possible conversion to type 2 diabetes and risk of death.
Portion sizes and caloric inequity: a hidden driver of obesity disparities
Sattar N, Sattar ZS, Sattar LJ and Gill JMR
Correction to Lancet Diabetes Endocrinol 2025; published online Nov 19. https://doi.org/10.1016/S2213-8587(25)00289-X
Diabetes and cancer in the age of multimorbidity
The Lancet Diabetes Endocrinology
Comorbidities and mortality in subgroups of adults with diabetes with up to 14 years follow-up: a prospective cohort study in Sweden
Asplund O, Thangam M, Prasad RB, Lejonberg C, Ekström O, Hakaste L, Smith JG, Rosengren AH, Oscarsson J, Carlsson B, Tuomi T, Hansson O and Ahlqvist E
Subgroups of adult-onset diabetes, namely severe autoimmune diabetes (SAID), severe insulin-deficient diabetes (SIDD), severe insulin-resistant diabetes (SIRD), and mild obesity-related diabetes (MOD) or mild age-related (MARD) diabetes, have been defined with clinical variables and a machine-learning approach. Our aim was to describe their long-term outcomes and mortality.
Adrenal tumour imaging: clinical, molecular, and radiomics perspectives
Pacak K, Blake MA, Sweeney AT, Jha A, Imperiale A, Zaidi H, Raffaelli M, Tüdös Z, Timmers H, Grossman A, Nölting S and Taïeb D
Adrenal tumours have become a common incidental finding in the radiological evaluation of patients. Estimates suggest that 1-10% of the general population currently harbours an adrenal tumour, peaking in prevalence in the seventh and eighth decades of life. Advances in CT and MR have contributed to improved characterisation of adrenal masses, and novel radiopharmaceuticals are being developed for molecular characterisation and disease subtyping. As a result, the imaging and management of adrenal tumours have been important subjects of many guidelines and consensus statements. New radiomics approaches, together with machine learning, are now being introduced and are quickly shaping the way that imaging data are analysed and interpreted. Furthermore, the development of theranostics links the molecular biology of functioning tumours to targeted treatment options. In this Review, we summarise up-to-date imaging and follow-up approaches for adrenal tumours to provide patients with the most accurate diagnosis, thereby avoiding unnecessary additional tests or surgery.
Glycaemic control and pregnancy outcomes with real-time continuous glucose monitoring in gestational diabetes (GRACE): an open-label, multicentre, multinational, randomised controlled trial
Linder T, Dressler-Steinbach I, Wegener S, Schellong K, Schmidt S, Eppel D, Monod C, Heinzl F, Redling K, Winzeler B, Mosimann B, Weschenfelder F, Groten T, Mittlböck M, Jendle J, Henrich W, Morettini M, Bozkurt L, Tura A, Göbl C and
Data regarding the impact of real-time continuous glucose monitoring (rt-CGM) on reducing adverse pregnancy outcomes in women with gestational diabetes are contradictory. We aimed to assess differences in the proportion of large-for-gestational-age (LGA) newborns between women using rt-CGM versus self-monitoring of blood glucose (SMBG).